Company intelligence / Profile preview

Falcon Capital Acquisition

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Falcon Capital Acquisition was a NASDAQ-listed SPAC formed in 2020 to effect a merger, which it accomplished in July 2021 by combining with Sharecare, a digital health engagement company. Falcon does not develop drugs, pursue therapeutic targets, or operate in the capacity of a biotech or healthcare company itself, but enabled the transition of Sharecare to a publicly traded entity under the symbol "SHCR".

Industry: Investors

Beyond the preview

Go deeper on Falcon Capital Acquisition.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Falcon Capital Acquisition.

Explore the full profile